VPS53 and posterior cortical atrophy: The PCa 22Rv1 cells harboring shRNAs against VPS53, FAM57A or GEMIN4 showed markedly attenuated cell growth and viability in comparison with cells harboring control shRNA in the proliferation assays (Fig. 7d–g).